592 related articles for article (PubMed ID: 24754714)
1. Animal models of chronic obstructive pulmonary disease.
Fricker M; Deane A; Hansbro PM
Expert Opin Drug Discov; 2014 Jun; 9(6):629-45. PubMed ID: 24754714
[TBL] [Abstract][Full Text] [Related]
2. Preclinical murine models of Chronic Obstructive Pulmonary Disease.
Vlahos R; Bozinovski S
Eur J Pharmacol; 2015 Jul; 759():265-71. PubMed ID: 25818750
[TBL] [Abstract][Full Text] [Related]
3. Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?
Churg A; Sin DD; Wright JL
Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1111-5. PubMed ID: 21685155
[TBL] [Abstract][Full Text] [Related]
4. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease.
Wright JL; Churg A
Expert Rev Respir Med; 2010 Dec; 4(6):723-34. PubMed ID: 21128748
[TBL] [Abstract][Full Text] [Related]
5. Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling.
Shin IS; Shin NR; Park JW; Jeon CM; Hong JM; Kwon OK; Kim JS; Lee IC; Kim JC; Oh SR; Ahn KS
J Pineal Res; 2015 Jan; 58(1):50-60. PubMed ID: 25388990
[TBL] [Abstract][Full Text] [Related]
6. Testing drugs in animal models of cigarette smoke-induced chronic obstructive pulmonary disease.
Churg A; Wright JL
Proc Am Thorac Soc; 2009 Sep; 6(6):550-2. PubMed ID: 19741268
[TBL] [Abstract][Full Text] [Related]
7. COPD and the response of the lung to tobacco smoke exposure.
Taylor JD
Pulm Pharmacol Ther; 2010 Oct; 23(5):376-83. PubMed ID: 20382250
[TBL] [Abstract][Full Text] [Related]
8. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.
Yoshida T; Tuder RM
Physiol Rev; 2007 Jul; 87(3):1047-82. PubMed ID: 17615396
[TBL] [Abstract][Full Text] [Related]
9. Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease.
Bracke KR; Verhamme FM; Seys LJ; Bantsimba-Malanda C; Cunoosamy DM; Herbst R; Hammad H; Lambrecht BN; Joos GF; Brusselle GG
Am J Respir Crit Care Med; 2013 Aug; 188(3):343-55. PubMed ID: 23742729
[TBL] [Abstract][Full Text] [Related]
10. Protocols to Evaluate Cigarette Smoke-Induced Lung Inflammation and Pathology in Mice.
Vlahos R; Bozinovski S
Methods Mol Biol; 2018; 1725():53-63. PubMed ID: 29322408
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of COPD: lessons learned from in vivo animal models.
Fujita M; Nakanishi Y
Med Sci Monit; 2007 Feb; 13(2):RA19-24. PubMed ID: 17261992
[TBL] [Abstract][Full Text] [Related]
12. Modelling COPD in mice.
Vlahos R; Bozinovski S; Gualano RC; Ernst M; Anderson GP
Pulm Pharmacol Ther; 2006; 19(1):12-7. PubMed ID: 16286233
[TBL] [Abstract][Full Text] [Related]
13. Animal models of cigarette smoke-induced chronic obstructive lung disease.
Churg A; Wright JL
Contrib Microbiol; 2007; 14():113-125. PubMed ID: 17684336
[TBL] [Abstract][Full Text] [Related]
14. Mast cells and COPD.
Mortaz E; Folkerts G; Redegeld F
Pulm Pharmacol Ther; 2011 Aug; 24(4):367-72. PubMed ID: 21463700
[TBL] [Abstract][Full Text] [Related]
15. 3-week inhalation exposure to cigarette smoke and/or lipopolysaccharide in AKR/J mice.
Lee KM; Renne RA; Harbo SJ; Clark ML; Johnson RE; Gideon KM
Inhal Toxicol; 2007 Jan; 19(1):23-35. PubMed ID: 17127640
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF).
Vlahos R; Bozinovski S; Hamilton JA; Anderson GP
Pharmacol Ther; 2006 Oct; 112(1):106-15. PubMed ID: 16716406
[TBL] [Abstract][Full Text] [Related]
17. What can in vitro models of COPD tell us?
Krimmer DI; Oliver BG
Pulm Pharmacol Ther; 2011 Oct; 24(5):471-7. PubMed ID: 21182977
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of COPD. Part III. Inflammation in COPD.
Roth M
Int J Tuberc Lung Dis; 2008 Apr; 12(4):375-80. PubMed ID: 18371261
[TBL] [Abstract][Full Text] [Related]
19. Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure.
Gosker HR; Langen RC; Bracke KR; Joos GF; Brusselle GG; Steele C; Ward KA; Wouters EF; Schols AM
Am J Respir Cell Mol Biol; 2009 Jun; 40(6):710-6. PubMed ID: 18988919
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological blockade of the DP2 receptor inhibits cigarette smoke-induced inflammation, mucus cell metaplasia, and epithelial hyperplasia in the mouse lung.
Stebbins KJ; Broadhead AR; Baccei CS; Scott JM; Truong YP; Coate H; Stock NS; Santini AM; Fagan P; Prodanovich P; Bain G; Stearns BA; King CD; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
J Pharmacol Exp Ther; 2010 Mar; 332(3):764-75. PubMed ID: 19996299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
